FFA
NRIX icon

Farther Finance Advisors’s Nurix Therapeutics NRIX Stock Holding History

Farther Finance Advisors’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4K Buy
469
+110
+31% +$1.87K ﹤0.01% 4338
2026
Q1 		$5.56K Buy
359
+16
+5% +$265 ﹤0.01% 4436
2025
Q4 		$6.51K Buy
343
+248
+261% +$3.56K ﹤0.01% 4167
2025
Q3 		$878 Buy
95
+86
+956% +$893 ﹤0.01% 4403
2025
Q2 		$103 Buy
+9
New +$97 ﹤0.01% 4312
2025
Q1 		– Sell
-14
Closed -$264 – 4373
2024
Q4 		$264 Hold
14
– – ﹤0.01% 3588
2024
Q3 		$315 Buy
14
+5
+56% +$113 ﹤0.01% 3544
2024
Q2 		$188 Hold
9
– – ﹤0.01% 3506
2024
Q1 		$131 Hold
9
– – ﹤0.01% 3335
2023
Q4 		$93 Buy
+9
New +$62 ﹤0.01% 3310

Other funds holding NRIX

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WFA
WestHill Financial Advisors San Rafael, California $587M AUM 20.13% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
ISWM
Intesa Sanpaolo Wealth Management Ville De Luxembourg $500M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Farther Finance Advisors's NRIX Position: Q2 2026 in Review

Farther Finance Advisors increased its Nurix Therapeutics (NRIX) stake by 31% in Q2 2026, buying an estimated $1.87K and bringing the position to 469 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4338.

Farther Finance Advisors first reported a position in NRIX in Q4 2023 and has held it in 10 quarters since. 19 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Farther Finance Advisors held 469 shares of Nurix Therapeutics worth $11.4K as of Q2 2026.
  • Farther Finance Advisors bought 110 Nurix Therapeutics shares in Q2 2026, an estimated $1.87K.
  • Nurix Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4338 holding.
  • Farther Finance Advisors first reported a position in Nurix Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • 19 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.